Teladoc Health (TDOC)
(Delayed Data from NYSE)
$12.73 USD
-0.17 (-1.32%)
Updated May 17, 2024 04:00 PM ET
After-Market: $12.74 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.73 USD
-0.17 (-1.32%)
Updated May 17, 2024 04:00 PM ET
After-Market: $12.74 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Zacks News
Cathie Wood Projects Market Rotation to Growth: ETFs to Play
by Sweta Jaiswal, FRM
Let's take a look at some ETFs poised to win from Wood's prediction of market rotation to growth investing.
American Well (AMWL) Down 59% YTD: Should You Still Hold?
by Zacks Equity Research
American Well (AMWL) is well placed in the booming telehealth industry on the back of its organic and inorganic growth profiles.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $139.29 in the latest trading session, marking a -1.96% move from the prior day.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $142.42 in the latest trading session, marking a +1.83% move from the prior day.
Amwell (AMWL) Buys Digital Care Startups to Enhance Market Share
by Zacks Equity Research
Amwell (AMWL) acquires digital health startups for fast expansion in the telehealth market.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $145.44 in the latest trading session, marking a -0.16% move from the prior day.
Teladoc (TDOC) Down 4.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
American Well (AMWL) Q2 Earnings Beat, 2H21 Visit View Cut
by Zacks Equity Research
American Well (AMWL) posts lower-than-expected loss for Q2. The spread of Delta variant compels the company to slash 2021 guidance.
Teladoc Health (TDOC) Q2 Loss Wider Than Expected, Worsen Y/Y
by Zacks Equity Research
Teladoc Health's (TDOC) Q2 earnings endure high expenses. Guidance shows tapering of growth.
Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of -45.76% and 0.43%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $152.87, moving -0.29% from the previous trading session.
Will Teladoc (TDOC) Q2 Earnings Show Weak Telehealth Demand?
by Zacks Equity Research
Teladoc's (TDOC) Q2 results are likely to reflect a rise in revenues but overall tepid demand as patients started visiting doctors' clinics for in-person checkups.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $153.32, marking a -0.98% move from the previous day.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dexcom's (DXCM) Digital Network Benefits From Latest FDA Nod
by Zacks Equity Research
Recent regulatory clearance of Dexcom's (DXCM) real-time APIs is expected to aid diabetics as well as their care providers in accessing GCM data.
Teladoc (TDOC), Microsoft Team Up to Offer Better Virtual Care
by Zacks Equity Research
Teladoc Health (TDOC) collaborates with Microsoft in a bid to ease administrative workflows for clinicians and offer enhanced virtual care to patients.
Teladoc (TDOC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $146.21, marking a -1.77% move from the previous day.
Here's Why You Should Hold Teladoc Health (TDOC) in Your Portfolio
by Zacks Equity Research
Despite a great run on the bourses last year, Teladoc Health (TDOC) suffers tepid demand while stiff competition calls for keeping a close watch on the stock.
Teladoc (TDOC) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $157.94, marking a -0.2% move from the previous day.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $164.64, marking a -0.99% move from the previous day.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $163.27, moving +1.73% from the previous trading session.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $156.31, moving +0.33% from the previous trading session.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $154.82 in the latest trading session, marking a +0.34% move from the prior day.
The Zacks Analyst Blog Highlights: GoodRx Holdings, American Well Corp, Accolade, SOC Telemed and Teladoc
by Zacks Equity Research
The Zacks Analyst Blog Highlights: GoodRx Holdings, American Well Corp, Accolade, SOC Telemed and Teladoc
Booming Telehealth Market Lures More IPOs and M&A Deals
by Sapna Bagaria
To make the most of the booming telehealth industry, players are coming up with IPOs and resorting to mergers and acquisitions.